Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61 | 110 | 266 | 48 | 0 |
| Receivables | 81 | 59 | 14 | 15 | 0 |
| Inventories | 345 | 354 | 375 | 177 | 0 |
| Other current assets | 66 | 63 | 63 | 0 | 0 |
| TOTAL | $584 | $637 | $790 | $272 | $0 |
| Non-Current Assets | |||||
| PPE Net | 44 | 34 | 28 | 18 | N/A |
| Intangibles | 70 | 62 | 53 | 36 | 0 |
| Other Non-Current Assets | 4 | 7 | 12 | 12 | 0 |
| TOTAL | $118 | $103 | $92 | $67 | $N/A |
| Total Assets | $702 | $739 | $882 | $338 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 187 | 129 | 179 | 179 | 0 |
| TOTAL | $373 | $236 | $238 | $205 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 254 | 200 | 160 | 0 | 0 |
| TOTAL | $254 | $200 | $160 | $N/A | $N/A |
| Total Liabilities | $627 | $436 | $399 | $205 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,012 | 52,012 | 52,012 | N/A | N/A |
| Common Shares | 54 | 52 | 52 | 52 | 0 |
| Retained earnings | -1,737 | -1,308 | -1,117 | -1,047 | 0 |
| Other shareholders' equity | -12 | -17 | -25 | -20 | 0 |
| TOTAL | $75 | $304 | $483 | $133 | $0 |
| Total Liabilities And Equity | $702 | $739 | $882 | $338 | $0 |